Trial Profile
Multidose pharmacokinetics of ordopidine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2008
Price :
$35
*
At a glance
- Drugs Ordopidine (Primary)
- Indications Bipolar disorders; Parkinson's disease
- Focus Pharmacokinetics
- Sponsors NeuroSearch
- 03 Jul 2008 New trial record.
- 26 Jun 2008 Results data reported in a NeuroSearch media release (9090561).